Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1977-04-08
1980-05-27
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 31195
Patent
active
042050880
ABSTRACT:
Pharmaceutically-acceptable compositions containing, as an active ingredient, at least one N-acylanilinobutyric acid have uses unrelated to the choleretic activity suggested in U.S. Pat. No. 3,780,095. Moreover, the further uses generally involve administration of smaller doses than would be required to obtain a choleretic effect.
The new uses include: (a) increasing the gastrointestinal enzyme secretion and (b) tonicizing the cardiovascular system. The increase of the gastrointestinal enzyme secretion is applied in the treatment of different diseases, such as treatment of sprue, treatment of indigestion, treatment of acute and chronic pancreatitis, therapy for degenerated intestine mucous membrane, treatment of stomach spasms, treatment of stomach ulcers, treatment of diseases where the application of an antigastrin is indicated. The tonicising of the cardiovascular system is applied in, e.g., increasing the circulation of blood in internal organs, increasing the heart force, treating disturbances in the liver function.
REFERENCES:
patent: 3780095 (1973-12-01), Klemm
PDR (1968) pp. 648, 771, 828, 948, 1138 & 1149.
Riedel Richard
Schoetensack Wolfgang
ByK Gulden Lomberg Chemische Fabrik GmbH
Waddell Frederick E.
LandOfFree
Compositions of and new uses for N-acylanilinobutyric acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions of and new uses for N-acylanilinobutyric acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions of and new uses for N-acylanilinobutyric acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1119890